WO2024012871 - ASSOCIATING A DESIGNATED USER WITH A MEDICAMENT DELIVERY DEVICE
National phase entry:
Publication Number
WO/2024/012871
Publication Date
18.01.2024
International Application No.
PCT/EP2023/067590
International Filing Date
28.06.2023
Title **
[English]
ASSOCIATING A DESIGNATED USER WITH A MEDICAMENT DELIVERY DEVICE
[French]
ASSOCIATION D'UN UTILISATEUR DÉSIGNÉ À UN DISPOSITIF D'ADMINISTRATION DE MÉDICAMENT
Applicants **
SHL MEDICAL AG
Inventors
HALLSTRÖM, Ola
CARLSSON, Daniel
RENSTAD, Rasmus
Priority Data
22184336.0
12.07.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2025 | |
| EPO | Filing, Examination, Granting | 8180 | |
| Japan | Filing, Examination, Granting | 2176 | |
| South Korea | Filing, Examination, Granting | 2051 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
20,372
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
A method of a receiver (11) of associating a designated user with a medicament delivery device configured to communicate a medicament delivery event wirelessly to the receiver (11) is provided. The method comprises receiving (S101) a wireless signal identifying a medicament delivery device (10, 12) communicating a medicament delivery event, determining (S102) whether or not timing of receiving the signal complies with an expected medicament delivery schedule of the designated user, and if so determining (S103) that the identified medicament delivery device (10) was used by the designated user for causing the medicament delivery event.[French]
L'invention concerne un procédé d'un récepteur (11) pour associer un utilisateur désigné à un dispositif d'administration de médicament configuré pour transmettre sans fil au récepteur (11) un événement d'administration de médicament. Le procédé comprend la réception (S101) un signal sans fil identifiant un dispositif d'administration de médicament (10, 12) transmettant un événement d'administration de médicament, la détermination (S102) du fait que le moment de réception du signal est conforme ou non à un calendrier d'administration de médicament attendu de l'utilisateur désigné et, si tel est le cas, la détermination (S103) du fait que que le dispositif d'administration de médicament identifié (10) a été utilisé par l'utilisateur désigné pour provoquer l'événement d'administration de médicament.